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Nitrogen metabolism ofMycobacterium tuberculosis
(Mtb) is crucial for the survival of this important path-
ogen in its primary human host cell, the macrophage,
but little is known about the source(s) and their
assimilation within this intracellular niche. Here, we
have developed 15N-flux spectral ratio analysis
(15N-FSRA) to explore Mtb’s nitrogen metabolism;
we demonstrate that intracellular Mtb has access to
multiple amino acids in the macrophage, including
glutamate, glutamine, aspartate, alanine, glycine,
and valine; and we identify glutamine as the pre-
dominant nitrogen donor. Each nitrogen source is
uniquely assimilated into specific amino acid pools,
indicating compartmentalized metabolism during
intracellular growth. We have discovered that serine
is not available to intracellular Mtb, and we show
that a serine auxotroph is attenuated in macro-
phages. This work provides a systems-based tool
for exploring the nitrogen metabolism of intracellular
pathogens and highlights the enzymephosphoserine
transaminase as an attractive target for the develop-
ment of novel anti-tuberculosis therapies.
INTRODUCTION
Tuberculosis (TB) is one of the top 10 causes of morbidity and
mortality in the human population, responsible for 1.6 million
deaths and 10 million new infections every year (WHO, 2018;
Flynn, 2006; Zumla et al., 2013). The causative agent of TB,
Mycobacterium tuberculosis (Mtb), primarily resides within the
hostile environment provided by the phagosome ofmacrophages
and can therefore resist stress conditions such as low pH, hypox-
ia, reactive oxygen species, reactive nitrogen species, and
nutrient starvation (Gouzy et al., 2014a; Russell, 2001; Rustad
et al., 2009). Metabolism within this restricted niche is key to
the survival and pathogenesis of Mtb (Beste et al., 2011; Ehrt
and Rhee, 2013; Eoh et al., 2017; Warner, 2014). Understanding3580 Cell Reports 29, 3580–3591, December 10, 2019 ª 2019 The A
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an important focus for research, with the aim of identifying vulner-
able metabolic pathways that could be targeted with drugs. Car-
bon metabolism in Mtb has been intensively investigated, and
host-derived lipids, cholesterol, and CO2 have been identified
as essential nutrients for intracellular growth and survival of TB
in animalmodels (Beste et al., 2011, 2013; Ehrt et al., 2018; Eisen-
reich et al., 2010; Gouzy et al., 2014b; McKinney et al., 2000; Nie-
derweis, 2008; Schnappinger et al., 2003). Our 13C-flux spectral
analysis (13C-FSA) approach, applied to the intracellular carbon
metabolism of Mtb, also demonstrated that several nonessential
amino acids are acquired byMtb frommacrophages, highlighting
their availability as potential nitrogen sources within the human
host. However, the identity of the primary nitrogen sources for
intracellular Mtb remains uncertain. Amino acid acquisition and
metabolism is important for the pathogenesis of several intracel-
lular bacterial pathogens, including Mtb (Das et al., 2010; Eylert
et al., 2008; Gouzy et al., 2013, 2014c; Kloosterman and Kuipers,
2011). For example, Salmonella enterica, Serovar typhimurium,
and Streptococcus pneumoniae require arginine for intracellular
survival and virulence (Das et al., 2010; Kloosterman and Kuipers,
2011), demonstrating that this amino acid is a nitrogen source.
Listeria monocytogenes has been shown to acquire aspartate,
alanine, and glutamate from the host macrophages for de novo
amino acid synthesis (Eylert et al., 2008). Isotopologue profiling
studies also identified the amino acid serine as a carbon and en-
ergy source for the growth and replication of Legionella pneumo-
philia (Eylert et al., 2010).
In vitro, Mtb can utilize a wide range of carbon sources but was
only able to utilize 13 out of 95 tested compounds as nitrogen
sources (Lofthouse et al., 2013). These included mainly the
following amino acids: alanine, asparagine, aspartate, valine,
glutamate, glutamine, ornithine, and serine. Agapova et al.
(2019) recently extended this list to include arginine, isoleucine,
and proline, and urea has previously been shown to be utilized
as a nitrogen source in vitro (Lin et al., 2012). The work by
Agapova et al. (2019) also demonstrated that growth rates and
yields are higher when Mtb grows with amino acids, as
compared with ammonium as nitrogen sources, and that
like carbon sources, Mtb can co-metabolize two amino acids
simultaneously in vitro. However, a comprehensive study touthor(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
identify the nitrogen sources for intracellular Mtb growing within
the host macrophage has never been performed.
The Mtb genome encodes several transporters for both inor-
ganic and organic nitrogen compounds (e.g., ammonium chlo-
ride [Amt] and nitrate [NarK2]), as well as ATP-binding cassette
(ABC) amino acid transporters (Cole et al., 1998). Aspartate
and asparagine have been detected in the Mtb phagosome,
highlighting these amino acids as potential intracellular nitrogen
sources. However, while the gene directing the transport of
aspartate (AnsP1) was essential for the synthesis of nitrogen-
containing compounds in a murine model of TB, this gene was
dispensable for intracellular survival, suggesting that aspartate
is not the primary nitrogen donor for Mtb growing within macro-
phages. Conversely, a study by the same group demonstrated
that the asparagine transporter (AnsP2) was required for surviv-
ing intra-phagosomal acid stress but was dispensable for in vivo
survival (Gouzy et al., 2013, 2014a). Glutamate dehydrogenase
(GDH), the enzyme that catalyzes the production of glutamate
from 2-oxoglutarate, is also essential for the intracellular survival
of Mtb (Cowley et al., 2004; Gallant et al., 2016; Viljoen et al.,
2013). However, GDH is also required for resistance to acidic
and nitrosative stress in Mycobacterium bovis (BCG); therefore,
the role of glutamate as a nitrogen source is uncertain. Mtb auxo-
trophic mutants of leucine, proline, tryptophan, and glutamine
have previously been shown to be severely attenuated in vivo
(Hondalus et al., 2000; Lee et al., 2006; Smith et al., 2001), indi-
cating that biosynthesis of these amino acids is required by Mtb
growing in the intracellular environment. Several other auxotro-
phic mutants (e.g., methionine, isoleucine, or valine) can, howev-
er, successfully proliferate in macrophages, indicating that these
amino acids can be acquired from the macrophage milieu
(Awasthy et al., 2009; McAdam et al., 1995). Mutagenesis
studies are useful in identifying Mtb genes required for nitrogen
uptake or metabolism during intracellular or in vivo survival; how-
ever, none of these studies have directly measured the uptake
and assimilation of nitrogen by intracellular Mtb.
Isotopic tracer studies, combined with direct interpretation of
the labeling patterns in metabolites, have emerged as a powerful
strategy to study the intracellular metabolism of important
pathogens (Buescher et al., 2015; Eylert et al., 2010). We previ-
ously used 13C isotopomer analysis and developed 13C-FSA to
identify the intracellular carbon sources for Mtb (Beste et al.,
2013). However, this approach was unsuitable for the current
study because of the lack of backbone rearrangements in the
metabolic network, as compared to carbon, and limited mass
isotopomer information from single nitrogen atoms. To over-
come these limitations, here we developed 15N-FSRA, a compu-
tational platform for analysis of the uptake of all potential amino
acids as nitrogen sources. Specifically, to counteract the limited
measurement information, an array of 15N labeling experiments
was conducted under equal conditions, which was simulta-
neously evaluated in an integrative system-based approach.
This work showed that Mtb uptakes and co-metabolizes multiple
intracellular sources of nitrogen when replicating within its hu-
man host macrophage. These results identify amino acid meta-
bolism as a target for TB therapeutics while also providing a
systems-based tool that can be applied to study the nitrogen
metabolism of other intracellular organisms.RESULTS
Mtb Co-assimilates Multiple Nitrogen Sources during
Intracellular Growth
To measure the uptake and assimilation of nitrogen during the
intracellular growth of Mtb, THP-1 humanmacrophages were in-
fected with Mtb in the presence of a 15N tracer—aspartate (Asp),
glutamate (Glu), glutamine (Gln), leucine (Leu), alanine (Ala), or
glycine (Gly)—for 48 h, the isotopic steady-state labeling period
established in our previous work (Beste et al., 2013). Asparagine
was not tested, as it had previously been shown to be a nitrogen
source for intracellular Mtb (Gouzy et al., 2014a). Proteinogenic
amino acids were used for isotopomer analysis because they
acquire the labeling pattern of their central metabolic precursors
and are abundant and stable (Beste et al., 2013) (Figure S1, I).
Using an identical method to that developed by Beste et al.
(2013), macrophage and Mtb fractions were separated, and
15N incorporation into proteinogenic amino acids from infected
macrophages and intracellular Mtb was measured using gas
chromatography-mass spectrometry (GC-MS). Amino acid pairs
of glutamate, glutamine and aspartate, asparagine (Asn) cannot
be distinguished using GC-MS due to acid hydrolysis, so the 15N
enrichments for these amino acid pairs are combined as gluta-
mate/glutamine (Glu/n) and aspartate/asparagine (Asp/n),
respectively. Experimental controls of uninfected THP-1 macro-
phages and in-vitro-grown Mtb were cultivated in Roswell Park
Memorial Institute (RPMI) containing each of the tracers for
48 h. These experiments established that the 15N labeling profile
of proteinogenic amino acids from intracellular Mtb was distinct
from that of Mtb in RPMI (Figures 1C and S1, II). For example, the
labeled nitrogen from 15N1-Leu was incorporated predominantly
into Leu when Mtb was tested in RPMI, but it was widely
dispersed into other amino acids for Mtb growing intracellularly
(Figure S1, IID). Similarly, for Mtb in RPMI, the label from 15N1-
Asp, 15N1-Glu, and
15N2-Gln was incorporated into Asp/n and
Glu/n. However, during intracellular growth, labeled nitrogen
from 15N1-Asp was incorporated into almost all measured amino
acids, including Asp/n and Glu/n (Figures S1, IIA–IIC). The
distinct 15N labeling profiles of intracellular Mtb versus in-vitro-
grown Mtb in RPMI demonstrated that there was negligible
cross-contamination from extracellular Mtb in these experi-
ments. Moreover, there was no cross-contamination during
the separation of the macrophage and the intracellular Mtb, as
evidenced by the unique labeling profile of proteinogenic amino
acids from these two fractions (Figures 1A and 1C). The labeling
profiles of proteinogenic amino acids from infected and unin-
fected macrophages were virtually identical, indicating that
Mtb infection does not significantly perturb the nitrogen meta-
bolism of macrophages (Figures 1A and 1B).
In accordance with expectations, most of the amino acids
derived from macrophages remained unlabeled, reflecting their
direct uptake from unlabeled nitrogen sources in the tissue
culture media rather than from any transamination from the
tracer (Figure 1A). This is not the case for intracellular Mtb.
For example, labeled nitrogen from 15N1-Asp,
15N1-Glu, or
15N2-Gln was incorporated predominantly into Asp/n, Glu/n,
and isoleucine (Ile) in the macrophage, but labeling was
measured in nearly all amino acids derived from intracellularCell Reports 29, 3580–3591, December 10, 2019 3581
Figure 1. Assimilation Pattern of Different Nitrogen Sources
(A–D) Heatmaps are shown for amino acids derived from Mtb-infected macrophages (A), uninfected macrophages (B), intracellular Mtb (C), and in-vitro-grown
Mtb in rosins minimal media (D). Assimilation patterns are shown for six tracers: 15N1-Asp,
15N1-Glu,
15N2-Gln,
15N1-Leu,
15N1-Ala, and
15N1 Gly. Essential amino
acids for macrophages are highlighted in blue. Heatmaps were produced using enrichment (%) of amino acids recorded for each of the individual tracer ex-
periments in Data S1. Themaximum andminimum enrichments for each heatmap are described using color keys. Enrichments are shown for the following amino
acids: alanine (Ala), m/z 260; glycine (Gly), m/z 246; valine (Val), m/z 288; leucine (Leu), m/z 274; isoleucine (Ile), m/z 274; methionine (Met), m/z 320; serine (Ser),
m/z 390; threonine (Thr), m/z 404; proline (Pro), m/z 258; phenylalanine (Phe), m/z 336; aspartate/asparagine (Asp/n), m/z 418; glutamate/glutamine (Glu/n), m/z
432; lysine (Lys), m/z 431; arginine (Arg), m/z 442; and tyrosine (Tyr), m/z 466, measured using GC-MS.Mtb (Figures 1A and 1C). These data also reveal potential
directions of transamination in Mtb. For example, nitrogen from
15N2-Gln was assimilated into six amino acids—Asp/n, Glu/n,
Ile, Leu, valine (Val), or Ala in infected macrophages (Fig-
ure 1A)—whereas in Mtb, eight additional amino acids were
labeled (Figure 1C). As the label fromGln has already been trans-
aminated into several amino acids in the macrophage, any of
those macrophage’s amino acids could be the source of the
Mtb’s labeled nitrogen.
NitrogenMetabolism Is CompartmentalizedwhenMtb Is
Growing Intracellularly
Our results demonstrate that nitrogen was assimilated differ-
ently, depending on the original amino acid source in intracel-
lular Mtb. We use the term ‘‘compartmentalization’’ to refer to
the selective transfer of nitrogen from the tracers to other
amino acids (Figure 1C). For example, nitrogen from 15N1-
Asp, 15N1-Glu,
15N2-Gln, and
15N1-Leu was incorporated into3582 Cell Reports 29, 3580–3591, December 10, 2019many additional amino acids, but nitrogen from 15N1-Ala and
15N1-Gly was incorporated predominantly into only Ala, Gly,
and serine (Ser) pools, respectively. The enrichment profiles
for amino acids obtained from the tracers were also distinct.
For example, more than 50% of 15N from 15N1-Asp was trans-
ferred to Glu/n: 15N1-Glu to six amino acids,
15N2-Gln to eight
amino acids, and 15N1-Leu to Ile (Figures 1C and 2A). Also,
some amino acids were preferentially labeled by particular
tracers. For example, the labeling of tyrosine (Tyr) indicates
that the nitrogen is transferred from 15N1-Glu/
15N2-Gln but not
from 15N1-Asp or any other tracers used. Similarly, nitrogen in
arginine (Arg) can be donated by 15N1-Asp, but not from any
other tested amino acid (Figure 1C). To investigate whether
the compartmentalized nitrogen distribution is restricted to
intracellular growth of Mtb, we performed similar 15N tracer ex-
periments with Mtb grown in Roisin’s minimal media, with glyc-
erol and ammonium chloride as the carbon and nitrogen
source, respectively, with the addition of 15N labeled tracers.
Figure 2. Nitrogen Assimilation is Compartmentalized in Mtb
(A) Distinct enrichment of amino acids from each of the tracers in intracellular Mtb.
(B) 15N assimilation from the tracers into the amino acids in in-vitro-grown Mtb.
(C) Comparison of 15N enrichment from the tracers 15N1-Glu and
15N2-Gln in an infected macrophage.
(D) Comparison of 15N enrichment from the tracers 15N1-Glu and
15N2-Gln in intracellular Mtb.
Values are mean ± SEM from 3–4 biological replicates. Statistically significant differences were calculated using Holm-Sidak multiple t tests; *p < 0.001.As can be seen, the results demonstrated compartmentalized
distribution of 15N from Asp, Glu, Gln, Leu, Ala, and Gly in to
the amino acid pools (Figures 2B and S2), extending the finding
of Agapova et al. (2019), who demonstrated the compartmen-
talized distribution of nitrogen from Gln and Asn during
in vitro growth of Mtb. It is noteworthy that the promiscuous
pattern of distribution of nitrogen from both 15N1-Ala and
15N1-Gly in vitro is very different from the restricted distribution
found for intracellular Mtb (Figures 1C, 2B, S3E, and S3F). To
check whether this promiscuous label distribution in in-vitro-
grown Mtb was biased by the experimental method, we har-
vested amino acids from in-vitro-grown Mtb using the same
method as described for intracellular Mtb. We found no differ-
ence in label distribution from 15N1-Ala and
15N1-Gly in in-vitro-
grown Mtb using the two methods, which confirmed that the
non-promiscuous pattern of these tracers in intracellular Mtb
was not experimentally biased (Figure S2, II). The non-promis-
cuous pattern for these two tracers in intracellular Mtb sug-
gests that these amino acids are scarce, in comparison to other
amino acids such as Gln within the Mtb phagosome, and are
therefore incorporated directly into biomass by Mtb, rather
than being used as nitrogen donors.Out of all the nitrogen sources tested, nitrogen from 15N2-Gln
was most widely distributed to other amino acids in intracellular
Mtb, suggesting that Gln is the principal nitrogen donor for Mtb
during intracellular growth (Figures 1C and 2A). The comparison
of enrichment profiles between 15N1-Glu and
15N2-Gln demon-
strated that both tracers gave similar 15N distribution patterns
in amino acids derived from an uninfected macrophage and an
infectedmacrophage (Figures 1A and 1B), but 15N2-Gln provided
significantly higher enrichments than15N1-Glu for the majority of
the intracellular Mtb amino acids (Figure 1C). Direct comparison
of 15N1-Glu and
15N2-Gln demonstrated that therewere no signif-
icant differences in enrichments between 15N1-Glu and
15N2-Gln
in the macrophage (Figure 2C). But in the case of intracellular
Mtb, using the tracer 15N2-Gln resulted in significant enrichments
for the majority of amino acids (Figure 2D).
Uptake versus De Novo Synthesis of Amino Acids in
Intracellular Mtb
To further evaluate the role of each macrophage amino acid pool
in the provision of nitrogen to intracellular Mtb, we calculated the
nitrogen incorporation ratio (NIR) between 15N enrichment of
amino acids in intracellular Mtb and the same amino acid inCell Reports 29, 3580–3591, December 10, 2019 3583
Figure 3. Uptake versus De Novo Synthesis of Amino Acids in Intracellular Mtb
(A–H) The NIR of 15N enrichment (%) in intracellular Mtb to infectedmacrophages is shown for Asp/n, m/z 418 (A), Glu/n, m/z 432 (B), Leu, m/z 274 (C), Ile, m/z 274
(D), Val, m/z 288 (E), Ala, m/z 260 (F), Gly, m/z 246 (G), and Ser, m/z 390 (H). An NIR of 1 indicates that the particular amino acid in Mtb was acquired directly from
the macrophage. NIRs were calculated from the enrichments measured from 3–8 individual macrophage infection experiments using the tracers 15N1-Asp,
15N1-
Glu, 15N2-Gln,
15N1-Leu,
15N1-Ala, and
15N1-Gly. Ratios that were not determined for Gly (G) and Ser (H) are indicated by ND, and the asterisk indicates maximum
15N detected in Mtb from 15N2-Gln.the host macrophage. Amino acids acquired directly from the
host that are not subject to any additional synthesis or meta-
bolism will have similar 15N enrichment as the macrophage
amino acids and an NIR of 1. De novo synthesis or additional
metabolic processes, such as transamination reactions, will be
revealed by different levels of 15N enrichment of amino acids in
Mtb, compared with that of macrophage amino acids. Figures
3A–3G show the ratio of 15N enrichment for seven amino acids
derived from intracellular Mtb compared with amino acids
derived from infected macrophages. Amino acids Val, Ile, and
Ala had an NIR of 1 for more than one tracer tested as the source
of label, suggesting the uptake of these amino acids is directly
from the macrophage by Mtb (Figures 3D–3F). Also, the NIR3584 Cell Reports 29, 3580–3591, December 10, 2019was >1 when 15N2-Gln was used as the tracer, suggesting the
biosynthesis of these amino acids in addition to the uptake.
Further clues as to the level of uptake versus biosynthesis can
be gleaned from closer inspection of the data. For example,
when 15N1-Asp was used as the label for the Asp/n pool, the
NIR was <1 (Figure 3A), indicating that any Mtb Asp/n imported
from the macrophage was being diluted with nitrogen from a
source that was less labeled than the macrophage Asp/n pool.
However, when 15N2-Gln was used as the tracer, the ratio for
the Asp/n pools was >4, indicating that any Mtb Asp/n imported
from the macrophage was being diluted with nitrogen from a
source that was at least 43 more labeled than Asp/n pools
from the macrophage. The same was not true when 15N1-Glu
was the source of the label. The obvious conclusion is that the
Asp’s nitrogen in Mtb is largely derived from the macrophage
Gln. Overall, using the tracer 15N2-Gln resulted in the highest
levels of labeling for the majority of the amino acids analyzed,
confirming our previous conclusion that Gln is the predominant
nitrogen donor for intracellular Mtb.
NIR analysis also revealed the exclusivity of nitrogen distribu-
tion in the Gly and Ser pools of intracellular Mtb (Figures 3G and
3H). Nitrogen from Gly is not promiscuous, as the label from
15N1-Gly remained with the Gly and Ser pools. Therefore, Gly
is not a nitrogen donor for Mtb. For Gly, a homologous labeling
with 15N1-Gly gave an NIR less than 1, indicating that Mtb’s
Gly pool is being diluted by a less labeled nitrogen source, but
not any of the tested amino acids, since none of them gave
significant levels of incorporation into Gly (Figure 3G). None of
the tracers tested provided nitrogen to Ser, except for Gly. The
NIR of Ser was 1 for the label from 15N1-Gly, indicating the
biosynthesis of Ser, in which imported Gly is converted to Ser
in intracellular Mtb (Figure 3H).
Development of 15N-FSRA to Probe the Uptake of
Nitrogen Sources from the Host by Mtb
Qualitative conclusions about the uptake of nitrogen sources
can be drawn from simple labeling patterns generated by
15N1-Ala and
15N1-Gly (Figures S3, I and II); however, the Fig-
ure S3 NIR does not account for the intracellular redistribution
of nitrogen. Here, we can use neither the traditional 13C
Metabolic Flux Analysis (MFA), since wewant to infer the uptake,
nor our former 13C-FSA tool, since we have to take too
many possible uptakes into account. We therefore developed
15N-FSRA to model the nitrogen source uptake by intracellular
Mtb. This approach inputs data from the 15N tracer experiments
into an in silicomodel of central nitrogen metabolism in Mtb, but
without making a prior assumption on the number or combina-
tion of potential nitrogen sources. The method calculates the
range of potential explanations in terms of nitrogen uptake flux
relative to biomass contribution, which is consistent with the
available labeling datasets simultaneously. We call this the flux
spectral range (FSR). The FSR of an amino acid gives an unbi-
ased possibilistic measure, reflecting the possible nitrogen
flows.
A 15N metabolic model was constructed for Mtb including ni-
trogen atom transitions and reaction reversibilities (Data S2; Fig-
ure S4). The model was able to analyze the amino acid pairs
Glu/Gln and Asp/Asn as separate pools and was solely con-
strained by the biomass equation taken from our previous
work (Beste et al., 2011). The uptake of 15N labeled amino acids
by Mtb was modeled by using the macrophage-derived amino
acid mass isotopomer distributions as potential intracellular ni-
trogen sources. The measurements of all six tracer experiments
were incorporated into the model. From the labeling data mea-
surements, histidine (His), Arg, cysteine (Cys), and tryptophan
(Trp) were excluded due to the low levels detected. The relative
FSRs (minimum ratio, median, andmaximum ratio) of amino acid
nitrogen uptake flux to the nitrogen content of each amino acid in
biomass were deduced (Data S3). For this analysis, amino acids
with minimum/maximum FSR of 1 indicated that this amino
acid is available in the macrophage and fully incorporated intoMtb’s biomass, whereas a minimum/maximum FSR of 0 indi-
cates that the amino acid is unavailable and must be completely
synthesized de novo byMtb. Aminimum ormaximum FSR >1 in-
dicates that the uptake of the amino acid is greater than the
biomass requirements; therefore, this amino acid is a likely nitro-
gen donor. It should be noted that amino acids with FSRs be-
tween 0 and 1 may still be nitrogen donors, but the deficit in their
uptake compared to biomass requirement must be made up by
de novo synthesis with an alternative nitrogen source.
15N-FSRA identified 14 amino acids (minimum ratio > 0) that
are available and taken up by intracellular Mtb from the macro-
phage (Table 1). Nine amino acids had FSRs between 0 and 1,
and the biomass nitrogen requirement was met by de novo
synthesis. The narrow FSR of 1 for Ala confirmed our previous
analysis that this amino acid was taken up by Mtb from the
macrophage and incorporated directly into the biomass. The
analysis showed that Gln and Val are both used as nitrogen
donors for the synthesis of other amino acids with high certainty
(minimum FSR > 1). For Asp and Gly, the minimum FSR was >0
and the maximum >1, and they are synthesized de novo but
could also be taken up by Mtb and used as nitrogen donors.
Furthermore, our results revealed that nine amino acids (Asn,
Ile, Leu, methionine [Met], Lys, Tyr, phenylalanine [Phe], proline
[Pro], and threonine [Thr]) are synthetized de novo to suffice
biomass requirements for growth in varying proportions, as
seen from the narrow ratio ranges. The roles of Ser and Glu as
nitrogen donors could not be resolved computationally, as the
minimum FSR was 0 (not taken up from the macrophage) and
maximum FSR > 1 (taken up in excess).
Serine Biosynthesis Is Essential for the Intracellular
Survival of Mtb
15N-FSRA predicted the minimum FSR of Ser to be 0, indicating
that therewas no uptake of this amino acid from themacrophage
and that its biosynthesis is essential for Mtb’s survival inside
the host. To test this prediction, we constructed a serine
auxotroph of Mtb and tested its survival in macropgaes. Ser is
biosynthesized in a multistep reaction using 3-phosphoglyceric
acid (PGA) as the precursor produced during glycolysis. Phos-
phoserine transaminase serC (Rv0884c) catalyzes the addition
of nitrogen to the carbon backbone of pyruvate to form Ser (Fig-
ure 4A; Bai et al., 2011). In addition to being a proteinogenic
amino acid, Ser provides the nitrogen backbone for the synthesis
of Gly and Cys and also replenishes the pyruvate pool in central
carbon metabolism (Figure 4A). Phosphoserine transaminase
serC, the enzyme that aminated pyruvate to form Ser, was pre-
dicted to be essential for the growth of Mtb in vitro (DeJesus
et al., 2017). Here, we successfully generated the DserC
H37Rv Mtb strain. The DserC strain failed to grow without Ser
supplementation, compared to the wild-type (WT) and the com-
plemented strain, DserC::serC (Figure 4B), confirming serine
auxotrophy. Unlike other nitrogen sources that were promiscu-
ous when tested in in vitro (Figure 1D), Ser was not a widely
assimilated in vitro nitrogen source; nitrogen from 15N1-Ser
was distributed predominantly to Gly (Figure 4C). This result
demonstrates the distinct nitrogen distribution between Ser
and Gly via serine hydroxymethyltransferase glyA1, glyA2
(Figure 4A) and was in concord with our earlier analyses inCell Reports 29, 3580–3591, December 10, 2019 3585
Table 1. Flux Spectral Ranges Determined with 15N FSRA
Category
Nitrogen
Source
Flux Spectral Range
Minimum Ratio Maximum Ratio Median
Y Asn 0.06 0.19 0.13
Y Pro 0.31 0.38 0.34
Y Thr 0.37 0.49 0.43
Y Ile 0.52 0.64 0.55
Y Tyr 0.57 0.63 0.60
Y Leu 0.58 0.96 0.61
Y Met 0.64 0.77 0.68
Y Phe 0.63 0.75 0.69
Y Lys 0.78 0.82 0.81
/ Ala 0.98 1 1
0/B Glu 0 1.63 0.02
0/B Ser 0 3.59 1.31
B Gly 0.51 3.17 0.67
B Asp 0.61 12.46 2.11
[ Gln 1.50 11.85 2.47
[ Val 1.82 13.45 2.88
Minimum and maximum FSRs for all computationally accessible amino
acids and the median of their distributions (Data S3). Amino acids are
grouped into five categories: Y, spectral ranges in the interval [0,1) indi-
cate that the biomass nitrogen need has to be fulfilled by de novo synthe-
sis of the amino acid;/, spectral range is essentially 1, nitrogen biomass
requirement is balanced with uptake, and no nitrogen is shared; 0, the
amino acid is not taken up; B, spectral range is inconclusive, as the
amino acid might be synthesized de novo, but may also be a nitrogen
donor; [, spectral ranges are larger then 1, indicating that this amino
acid is available as a nitrogen donor.Figures 1C and 3H. Furthermore, DserCwas strongly attenuated
for intracellular survival in THP-1 macrophages, as compared
with WT H37Rv and the complemented strain (Figures 4D and
4E). These data validate the 15N-FRSA predictions and confirm
that serine biosynthesis is essential for the intracellular survival
of Mtb.
DISCUSSION
We and others have shown that Mtb co-metabolizes multiple
carbon sources during intracellular growth in the human host
cell (Beste et al., 2013; Ehrt et al., 2018; McKinney et al.,
2000). Here, we demonstrate that this is also the case for nitro-
gen. Using 15N isotopomer profiling and 15N-FSRA systems-
based inference tool, we describe the first nitrogen metabolic
phenotype of Mtb inside human macrophages (Figure 5). With
the 15N-FSRA tool, we predicted that Mtb has access to most
amino acids within the macrophage (Table 1), and this uptake
was insufficient tomeet the biomass requirement for most tested
amino acids and therefore must be complemented with de novo
synthesis from nitrogen donors. This analysis identified the
amino acids Asp, Glu, Gln, Val, Leu, Ala, and Gly as the intracel-
lular nitrogen sources utilized by Mtb in human macrophages.
Further analysis of the data demonstrated that, like carbon
metabolism in Mtb (de Carvalho et al., 2010), nitrogen meta-3586 Cell Reports 29, 3580–3591, December 10, 2019bolism is compartmentalized (Figures 1C and 1D). Our in vitro
results (Figure 1D) are consistent with the results of Agapova
et al. (2019), who demonstrated that Mtb does not show a pref-
erence for any amino acids as nitrogen sources when grown
in vitro. However, in this study, we demonstrate that this is
clearly not the case for Mtb growing inside macrophages.
Instead, the principal nitrogen source for intracellular Mtb ap-
pears to be Gln, but there is a clear pattern of compartmentaliza-
tion of distribution of nitrogen with some sources: Gln is a highly
promiscuous nitrogen donor, whereas other amino acids, such
as Gly and Ala, have a restrictive pattern of nitrogen distribution.
Metabolism has been shown to be compartmentalized in other
bacteria with microcompartments, such as carboxysomes and
metabolosomes, serving to compartmentalize enzymes involved
in particular pathways and to restrict the exposure of toxic inter-
mediates to the rest of the cell (Frank et al., 2013). For example,
in Salmonella enterica, activity of the metabolosome was
required to alleviate acetaldehyde toxicity during ethanolamine
catabolism (Brinsmade et al., 2005). In the case of intracellular
Mtb, different nitrogen sources might be assimilated using en-
zymes that are similarly localized. For example, enzymes gluta-
mine synthetase and asparaginase are demonstrated to function
extracellularly for the catabolism of Gln and Asn, respectively, in
Mtb (Harth et al., 1994; Gouzy et al., 2014a) as a strategy to resist
acidic stress inside the phagosome.
Earlier studies demonstrated that Asp is an intracellular nitro-
gen source for Mtb, and the pathways for Asp/n assimilation
were recently described (Gouzy et al., 2013, 2014a). However,
although our results confirm that Asp is indeed a nitrogen source,
they also demonstrate that, of the tested amino acids, Gln is the
principal source of nitrogen for intracellular Mtb and is the
amino acid whose nitrogen is most widely assimilated (Fig-
ure 1C). Gln is the major fuel for a variety of mammalian cells
including macrophages (Zhang et al., 2017), and THP-1 macro-
phages have previously been shown to assimilate Gln into Glu
(Amorim Franco et al., 2017; Zhao et al., 2013; Choi and Park,
2018). Our previous study demonstrated that carbon from both
Glu and Gln was available to Mtb inside the macrophage (Beste
et al., 2013). Here, we additionally show that Gln, and not Glu, is
the predominant nitrogen donor for intracellular Mtb. Once in
Mtb, Gln can be converted to Glu by glutamate synthase (GltB)
(Lee et al., 2018), and the nitrogen is transferred to other amino
acids by various transaminases (Figure 5). Our results are
thereby consistent with previous studies that have demonstrated
that Glu/n biosynthesis is essential for the intracellular growth
and survival of Mtb (Harper et al., 2008; Gallant et al., 2016; Ven-
tura et al., 2013; Tullius et al., 2003). In addition to being the ni-
trogen donor for other amino acids, Glu/n is also involved in
cell wall synthesis and resisting acid and nitrosative stress (Harth
and Horwitz, 2003; Wietzerbin-Falszpan et al., 1973; Read et al.,
2007). These studies, together with our results, establish Glu/n
as the hub of nitrogen metabolism in intracellular Mtb. Gln was
involved in modulating host cellular immune responses (Dos
Santos et al., 2017), and Mtb infection increased macrophage’s
metabolic dependency on Gln (Cumming et al., 2018). We found
no significant changes in macrophage’s 15N2-Gln assimilation
profile upon infection by Mtb (Figure 1A), but there could be
an increase in the pool sizes of Gln and its related pathway
Figure 4. Serine Biosynthesis Is Essential for the Intracellular Survival of Mtb
(A) Metabolic role of serC in Mtb. serC catalyzes the production of serine from pyruvate. Gly, Cys, and pyruvate are synthesized from Ser.
(B) Growth of wild-type (WT), DserCmutant, and complement DserC::SERC in 7H9 medium supplemented with 10% oleic acid, albumin, dextrose, and catalase
(OADC) tested with and without the addition of Ser. Data are the average of three biological replicates ± SD.
(C) Assimilation of 15N1-SER by WT, DserC, and DserC::SERC in Rosin’s minimal medium with glycerol and NH4Cl. Data are the average of three biological
replicates ± SD.
(D) Growth of WT, DserC, and DserC::SERC in THP-1 macrophages. CFUs (colony forming units) of the three strains were recorded for 0 (before infection), 1, 3,
and 7 days post-infection.
(E) Fold change in CFUs of the three strains over the period of infection.
Data are the average of six independent infection experiments, each with three technical replicates for WT and DserC and one for infection with four technical
replicates for DserC::SERC ± SD. Statistically significant reduction in CFU counts and fold change in CFUs for DserC as compared to the WT and complement
was calculated using Student’s t test. *p < 0.05; ***p < 0.0005. PPP, pentose phosphate pathway; TCA, tricarboxylic acid cycle; 3P-HPyr, 3-phosphonoox-
ypyruvate; 3P-Ser, 3-Phosphoserine; Cys, cysteine; PGA, 3-phosphoglyceric acid; PYR, pyruvate; PEP, phosphoenolpyruvate; GAP, glyceraldehyde 3phos-
phate; DHAP, dihydroxyacetone phosphate; G6P, glucose-6-phosphate; F6P, fructose 6-phosphate; FBP, fructose bisphosphate; PG6, phosphoglucono-
lactone; RU5P, riboluse 5-phosphate; R5P, ribose 5-phosphate; E4P, erythrose 4-phosphate; S7P, sedoheptoluse 7-phsophate; X5P, xylulose 5-phosphate;
ACCCOA, AcetylCoA; OAA, oxaloacetic acid; MAL, malate; FUM, fumarate; SUC, succinate; SUCCOA, succinyl CoA; OXG, 2-oxoglutarate; ICIT, isocitrate; CIT,
citrate.intermediates. This leads to an intriguing hypothesis that Mtb
may facilitate its own intracellular survival by metabolizing Gln
in the host, and targeting Glu/n transport and metabolism there-
fore represents a promising avenue for the development of anti-
TB drugs.
Biosynthesis of branched chain amino acids is also essential
for the intracellular survival of Mtb (Awasthy et al., 2009). Here,
we show that the branched chain amino acid Val is acquired
directly by intracellular Mtb and is utilized as a nitrogen donor
in addition to Gln (Figure 3; Table 1). Val was not directly
tested as a tracer for the 15N experiments in the macrophageand intracellular Mtb, but the Val pool was 15N labeled from all
of the amino acid tracers (except for 15N1-Ala and
15N1-Gly),
suggesting that nitrogen was shared between Val and other
amino acids. A Val auxotroph of Mtb was able to survive in
macrophages (Awasthy et al., 2009); this is consistent with
our FSRA predictions that intracellular Mtb acquired Val from
the host. Nitrogen from Val is reversibly transaminated to
Glu, Ile, and Leu by ilvE, the branched chain transaminase
that is required for mycobacterial survival during infection in
the mice model (Grandoni et al., 1998; Sassetti and Rubin,
2003; Tremblay and Blanchard, 2009). The demonstration byCell Reports 29, 3580–3591, December 10, 2019 3587
Figure 5. Schematic Representation of Ni-
trogen Metabolism (Acquisition and Assimi-
lation) in Intracellular Mtb
Macrophages acquires nitrogen sources Asp
(aspartate), Glu (glutamate), Gln (glutamine), Leu
(leucine), Ala (alanine), and Gly (glycine) directly
from the growth media. Glu/Gln is taken from the
host via yet-unidentified transporter. Asp is
accessible to intraphagosomal Mtb, which it up-
takes from the host macrophages via AnsP1
(Gouzy et al., 2014a). Leu, Ile (isoleucine), and Val
(valine) are acquired from the host macrophages
via yet-unindentified branched chain amino acid,
probably an ABC-type transporter. Ala, Gly, and
Ser are possibly acquired via CycA transport sys-
tem. Gln, Val, and Asp were potential nitrogen
donors for cellular protein synthesis, with Gln as
the principal nitrogen donor in intracellular Mtb
(indicated by asterisk). Nitrogen from Gln was
transaminated primarily to Glu and Asp for the
synthesis of other amino acids. Ala and Gly are
assimilated mainly into Ala, Gly, and Ser pools.
Limited transamination of nitrogen from Ala and
Gly to other amino acids suggests direct assimi-
lation of these two amino acids for biomass-cell
wall synthesis.Zimmermann et al. (2017) that the biosynthetic genes for
branched chain amino acids were downregulated when Mtb
was growing intracellularly in macrophages is consistent with
our evidence that these amino acids are also available in the
phagosome. Our finding that nitrogen from Leu is assimilated
by intracellular Mtb is surprising, since a DleuD auxotroph of
Mtb was shown to be severely attenuated for growth and viru-
lence in murine bone-marrow-derived macrophages and in
mice, suggesting that Leu was unavailable to Mtb growing
within its host (Chen et al., 2012; Hondalus et al., 2000; Samp-
son et al., 2004). The 15N-FSRA showed that Leu uptake is
insufficient for Mtb’s biomass requirements, indicating that
the uptake must be supplemented by de novo synthesis,
consistent with the auxotrophic results.
Our previous work showed that the carbon backbone of Ala
was acquired from the host and directly incorporated into
Mtb’s biomass (Beste et al., 2013). Here, we show that Ala
was not a nitrogen donor for intracellular Mtb (Figure 1C; Table
1). Gly was also a nitrogen source for intracellular Mtb, but
its nitrogen was similarly not widely assimilated. Both Ala
and Gly are components of the mycobacterial cell wall (Alder-
wick et al., 2015; Mahapatra et al., 2005; Wietzerbin-Falszpan
et al., 1973), so it seems likely that these amino acids acquired
from the host are directly incorporated into cell wall synthesis
(Beste et al., 2013). 15N-FSRA predicted zero uptake of Ser,
suggesting that its biosynthesis may be essential for the intra-
cellular replication of Mtb and thereby a potential drug target.
To test this hypothesis, we constructed a Ser auxotroph of
Mtb and demonstrated that it is severely attenuated for growth
in the macrophage. Our findings validate our systems-based3588 Cell Reports 29, 3580–3591, December 10, 2019approach and highlight Ser biosynthesis, and particularly the
transaminase serC, as a potential drug target.
In addition to biosynthesis, the transport systems of nitrogen
sources are potential targets for anti-TB drug development.
However, there is only limited knowledge of the amino acid
transport systems inMtb (Cook et al., 2009). The Asp transporter
AnsP1 is essential for the virulence of Mtb in murine models
(Gouzy et al., 2013). Although Glu and branched chain amino
transport systems are yet to be identified, the Streptococcus
mutans and Lactococcus lactis glnQHMP system is known to
transport Glu (Krastel et al., 2010; Fulyani et al., 2015), and
Mtb encodes GlnQ and GlnP homologs that could function as
Glu/n transporters (Cole et al., 1998; Braibant et al., 2000). The
common transporter for Ala, Gly, and Ser, cycA, also remains un-
studied (Awasthy et al., 2012; Chen et al., 2012; Cole et al., 1998).
Further investigations are required to define these amino acid
transporters of Mtb.
In summary, we describe the first nitrogen metabolic pheno-
type of intracellular Mtb and the development and application
of a novel computational systems-based tool, 15N-FSRA, to
investigate nitrogen uptake and assimilation of not only Mtb,
but also any intracellular pathogen, in complement with direct
isotopic labeling interpretation. In conclusion, we have identi-
fied that multiple nitrogen sources are acquired and assimi-
lated by Mtb inside the host macrophages, and Gln is the
principal intracellular nitrogen donor. The biosynthetic and
transport systems of these identified nitrogen sources—and
in particular, phosphoserine transaminase—involved in Ser
biosynthesis are a target for the development of innovative
anti-TB therapies.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Sources of Mycobacterium tuberculosis, E. coli and cell lines used for this study are reported in the Key Resources Table.
METHOD DETAILS
Mycobacterium tuberculosis (Mtb) cultivation
Mtb, H37Rv was cultivated on Middle brook7H11 agar and Middlebrook 7H9 broth with 5% (v/v) oleic acid-albumin-dextrose-cata-
lase enrichment supplement and 0.5% (v/v) glycerol. Roisins minimal media was prepared with the composition described in Beste
et al. (2011) and supplemented with 0.5% glycerol (v/v) as the carbon source and 10mM NH4Cl as nitrogen source, 0.1% tyloxapol
(v/v) at 37C with agitation (150 rpm).
THP-1 macrophage cultivation
The human monocytic THP-1 cell line was grown in RPMI 1640 medium supplemented with 10% heat inactivated fetal calf serum at
37C, 5%CO2 and 95%humidity. For
15N labeling experiments, modified RPMI supplemented with 0.2mM L-glutamine was used for
testing 15N1 aspartic acid and
15N1 glutamic acid.RPMI without L-glutamine was used for testing
15N2 glutamine (sigma). RPMI-1640
with 200 mM L-glutamine was used for testing 15N1 leucine,
15N1 ala and
15N1 glycine.
15N isotopic labeling during infection of macrophages with Mtb
For infection, THP-1 cells andMtb cultures were prepared as described in Beste et al., 2013. THP-1 cells (3 X 107) were differentiated
into macrophages for 3 days using 50 nM Phorbol 12-myristate 13-acetate in a 175 cm2 tissue culture flasks. Macrophages were
washed with warm PBS supplemented with 0.49 mM Mg2+ and 0.68 mM Ca2+ (PBS+) and 30 mL of RPMI media was added. Mtb
was grown in 7H9 broth for a week to an optical density of 1 (13 108 colony forming units per ml). Mtb cultures were washed 3 times
with PBS and resuspended in RPMI media and added to the macrophages at a multiplicity of infection- 5. Each amino acid tracer
except for 15N2 glutamine was then added to the Mtb-infected macrophages at 3 times the concentration of that unlabelled amino
acid present in the RPMI. For 15N2 glutamine experiment, RPMI without unlabelled glutamine was used, because a large amount of
unlabelled glutamine was present in RPMI as compared to other amino acids. To reduce the costs of the 15N2 glutamine labeling
experiment, the only glutamine in this RPMI was the tracer itself, added at 1 mM concentration which previously demonstrated
by Tullius et al., 2003 and also confirmed in this study to have no detrimental effect on the macrophages (data not shown). The final
concentration of tracers added during infection were- 0.6 mM 15N1 aspartic acid, 0.53 mM
15N1 glutamic acid, 0.8 mM
15N1 leucine,
0.3mM 15N1 alanine, 1mM
15N2 glutamine and 0.4mM
15N1 glycine. Mtb infectedmacrophages were incubated for 3-4 h at 37
C, 5%
CO2 and 95% humidity. After incubation, macrophages were washed 3 times with PBS, tracers were added and left for 48 h at 37
C,
5% CO2 and 95% humidity. After incubation for 48 h, macrophages were washed with cold PBS and Mtb cultures were harvested
from macrophages using differential centrifugation (Beste et al., 2013). Amino acid hydrolysates were prepared from macrophage
and Mtb using 6 M hydrochloric acid and incubation at 100C for 24 h. The validity of the method for labeled amino acid extraction
from intracellular Mtb was confirmed by comparing the nitrogen assimilation pattern obtained in RPMI grown labeled Mtb (control)
(Figure S1, II). The control was set up bywashingMtb cultures with PBS and resuspending in RPMI for 48 hwith equal amounts of 15N
isotope tracers that was previously used for infection assays. After 48 h, Mtb in RPMI were harvested followed preparation of amino
acid hydrolysate.Cell Reports 29, 3580–3591.e1–e4, December 10, 2019 e2
In vitro 15N isotopic labeling
Mtbwas grown in Roisinsminimal spikedwith 15N isotope tracers and left for 48 h at 37Cand cultures were agitated at 150 rpm. After
48 h, Mtb cultures were washed with triton, PBS and RIPA buffer. Cultures were harvested and amino acid hydrolysate was prepared
by boiling Mtb in 6M hydrochloric acid for 24 h.
Gas-chromatography mass spectrometry (GC-MS) and 15N mass isotopomer analysis
Amino acid hydrolysates were dried and derivatized using pyridine and tert-butyldimethyl silyl chloride (TBDMSCl) (sigma) (Rossi
et al., 2017; Masakapalli et al., 2013). Amino acids were analyzed using a VF-5ms inert 5% phenyl-methyl column (Agilent Technol-
ogies) on a GC-MS system.MS data were extracted using chemstation GC-MS software andwere baseline corrected usingMetalign
(Lommen, 2009). Mass data were corrected for natural isotope effects using Isotopomer network compartmental analysis (INCA)
platform (Young, 2014). Average 15N in an amino acid was calculated from the fractional abundance of the mass isotopomer in
the entire fragment. For this study measurements > 1% were considered to be significantly enriched by the 15N tracers.
Nitrogen network model (of Mtb)
A nitrogen transition model was set up for Mtb using information available in databases (KEGG, BioCyc, Tuberculist) and literature.
The network model comprises the amino acid biosynthesis pathways of all 20 proteinogenic amino acids, as well as a simplified
nucleotide biosynthesis formulation. Reaction reversibilities and requirements for growth were taken from Beste et al. (2011). For
20 protein-derived amino acids unidirectional uptake reactions were formulated while it was assumed that no backflow of nitrogen
from Mtb to the phagosome exists. The mass isotopomers observed in the macrophage were deconvolved into distributions of
isotopomer species and modeled by additional reactions (Figure S4). For comparability of the inference results across different ni-
trogen uptake constellations, flux values were formulated relative to the biomass synthesis rate. In total, the model has 98 indepen-
dent fluxes, from which 50 are intracellular (40 net, 10 exchange) and 48 nuisance fluxes for modeling the deconvolution of the
substrate species. This nitrogen transition template model was then duplicated per dataset to give rise to a sextuple model (Beyß
et al., 2019), where each sub-model shared flux values, biomass requirements, and growth rate. Eventually, the sextuple model
had 338 free fluxes (50 intracellular and 288 nuisance fluxes) that had to be inferred from 264 independent labeling measurements
(15 measurement groups for Mtb and the host, respectively (Data S2; Figure S4).
15N Flux Spectral Range Analysis (15N-FSRA)
15N-FSRA borrows the concept of parallel data integration from COMPLETE-MFA (Leighty and Antoniewicz, 2013) which, however,
was reformulated resigning the knowledge of the experimentally inaccessible specific amino acid uptake rates and amending the
traditional least-squares fitting approach by a tailored regularization approach to punish model complexity. In short, a penalty
term was added to the weighted least-squares functional
min
v
kymeas  ysimk2S + l1kvk1 + l2kvk22 (1)
where v are the (independent) fluxes, ymeas; ysim the measured/simulated data,S the measurement covariance matrix, and li ; i = 1; 2
regularization parameters punishing non-zero flux values (l1 = 10:0 and l2 = 0:1).
Amulti-start optimization strategy was applied to safeguard against local minimawhile solving Equation (1). The flux fitting proced-
ure was performed with the high-performance simulator 13CFLUX2 (Weitzel et al., 2013) using the multifitfluxes module with 1,000
randomly sampled starting points and the NAG C optimization library (Version 6.23, Oxford, UK) with a maximum number of 250 it-
erations. From the 1,000 runs, those with residuals less than a cut-off of 203.5 were accepted (the overall optimal residual value was
182.01, corresponding to a c2 value > 99.99%, Data S3 and S4). This resulted in 800 accepted fits. From these accepted estimated
flux distributions, FSRs (minimum, maximum, median) for each flux were derived (Table 1). Histograms of all FSRs are available in
supplemental data file S4.
Construction of serC (Rv0884c) knockout strain of H37Rv
The knockout (KO) strainDserCwas constructed using the bacteriophagemediated transduction of wild-type H37Rv (Bardarov et al.,
2002). The strains and plasmid and primers used for this work are listed in Table S1A, B. Briefly, the allelic exchange vector was con-
structed by cloning upstream and downstream flanking regions of serC gene into the cosmid vector pYUB854with res sites flanking
the hygromycin resistance (HYGR) gene. The recombinant cosmid with the allelic exchange substrates was cloned into the PacI site
of the temperature sensitive shuttle phasmid phAEB159 using an in vitro l-packaging reaction (GIGA PackII). The mycobacterio-
phage containing the recombinant pYUB854 was used for transduction of H37Rv. Bacterial cultures were grown up to exponential
phase and washed with pre-warmed 7H9 no tween at 37C. Phage was added at an m.o.i of 10 and incubated at 37C for 4 h. After
infection, cells were spun and plated onto 7H11 agar plates containing 100 mg ml-1 hygromycin and 50 mg ml-1 L-serine. Plates were
incubated for 3 weeks and single colonies were picked for mutant screening. The knockout strain was confirmed by whole genome
sequencing analysis where serC gene was deleted in H37Rv (Figure S6A, S6B; Data S5).e3 Cell Reports 29, 3580–3591.e1–e4, December 10, 2019
Construction of the complement strain DserC::SERC H37Rv
The complement strain was constructed using the integrating shuttle plasmid pMV361 with hsp60 promoter E. coli origin of replica-
tion (oriE), the attP and int genes of mycobacteriophage L5 (for integration in themycobacterial chromosome) and a kanamycin resis-
tance gene (Kanr) (Stover et al., 1991). serC was amplified using wild-type H437Rv genomic DNA as the template and primers with
EcoRI and HindIII restriction site (Table S1). The amplified fragment was cloned into pMV361 EcoRI and HindIII sites downstream of
the hsp60 promoter. The recombinant plasmid was transformed intoE. coliDH5a competent cells and plated onto LB agar containing
50 mg ml-1 kanamycin. Transformants were confirmed by digestion of the pMV361serC construct with EcoRI and HindIII. The
construct was electroporated into the KO strain DserC and plated onto 7H11 agar plates containing 100 mg ml-1 hygromycin and
25 mgml-1 kanamycin. Plates were incubated for 3 weeks and single colonies were picked for complement strain screening. Genomic
DNA of the complement strain was isolated and the fragment containing hsp60 promoter and serC gene was amplified. The comple-
ment strain had a PCR product of size 923 kb, identical to that of the construct pMV361serC confirming the complementation of the
KO strain Figure S7B.
Growth of DserC and DserC::SERC H37Rv strains
For cultivation in agar plates, strains were grown in 7H11 agar supplemented with OADC. For DserC L-serine was added to the
7H11 + OADC plates at a concentration of 5mM and hygromycin at 100 mg ml-1. For DserC::SERC H37Rv, kanamycin was added
at 25 mg ml-1 to the 7H11 + OADC plates. For liquid cultures, strains were grown in 7H9 medium with OADC. To test for auxotrophy,
DserCwas grown in 7H9 with and without 5mM L-serine. WT and complement was grown in parallel in 7H9mediumwith and without
serine for comparison with the mutant.
Macrophage infections with WT, DserC and DserC::SERC H37Rv strains
THP-1macrophages were cultivated as described in Beste et al. (2013) and 5 X 105 cells were seeded for each infection. WT, mutant
and complement strains were added to the macrophages at an m.o.i of 0.1 for 4 h. After 4 h macrophages were washed and fresh
RPMI mediumwith 10% FBSwas added. Macrophage survivability upon infection with the strains wasmonitored using crystal violet
assays during the period of infection (data not shown). For bacterial survivability test, macrophages were lysed with 0.1% Triton
X-100 at specific time points- 0 (inoculum before infection of macrophage), day 1, day 3 and day 7, and plated on 7H11 agar plates
with OADC. 7H11 plates for DserC strain were supplemented with 5mM serine and hygromycin was added at 100 mg ml-1, and for
DserC::SERC strain, kanamycin was added at 25 mg ml-1. Plates were incubated for 3 weeks at 37C and colony forming unit ml-1
were recorded for the three strains.
15N1-serine isotopic labeling
Starter cultures of WT, mutant and complement strains were cultivated in 7H9 medium with OADC, 5mM L-serine and respective
antibiotics for 4-5 days. For labeling experiments, starter cultures were spun and re-suspended Roisin’s minimal medium containing
glycerol and ammonium chloride as carbon and nitrogen sources respectively, and with 50 mg ml-1 15N1-serine. Cultures were incu-
bated for 48 h at 37C. After incubation, cultures were spun and amino acid hydrolysates were prepared as described previously. 15N
enrichment of amino acids was performed with GC-MS as described previously.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses were performed using Student’s t test and significant differences were calculated using Holm Sidak method in
graph pad prism 8.0. The details of number and type of replicate measurements used for calculating mean and standard error of the
mean (SEM) are included in figure legends. Residual values for FSRA predictions (minimum, maximum, median) were calculated in
13CFLUX2 software and are described in details in the methods section.
DATA AND CODE AVAILABILITY
Data generated in this study are available in the supplemental itemsCell Reports 29, 3580–3591.e1–e4, December 10, 2019 e4
